FDA Creates CMC Pilots To Put Quality Assessment Principles Into Practice
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA and ANDA pilot programs will help transform the way CMC information is submitted and reviewed by FDA. Office of Generic Drugs' white paper on "question-based review" follows the introduction of an NDA pilot program in mid-July.
You may also be interested in...
Industry Views On Quality-By-Design, Specifications To Be Presented At Cmte. Meeting
PhRMA, GPhA and USP will make presentations at Oct. 25-26 meeting of the Advisory Committee for Pharmaceutical Science. Question-based review for quality assessment will also be discussed.
GMP “Design Space” To Facilitate FDA Quality Initiative Implementation
“Design Space” is emerging as a pivotal concept in FDA’s effort to integrate its pharmaceutical application review and inspection operations into a new “quality assessment” system. With regulatory flexibility for manufacturing changes in the balance, the agency will be working with industry to refine the concept and its application in drug development and manufacturing.